# The Effect of the Interaction of Glucagon and Insulin on Endogenous Glucose Production in Humans

> **NCT04461015** · PHASE3 · COMPLETED · sponsor: **Adrian Vella** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 0.4mU Insulin followed by withdrawal period followed by 0.8mU study
- **DRUG:** 0.8mU Insulin followed by withdrawal period followed by 0.4mU study

## Key facts

- **NCT ID:** NCT04461015
- **Lead sponsor:** Adrian Vella
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-14
- **Primary completion:** 2021-07-30
- **Final completion:** 2022-01-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04461015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04461015, "The Effect of the Interaction of Glucagon and Insulin on Endogenous Glucose Production in Humans". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04461015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*